Hirotsugu Ariizumi, Miyuki Shimazui, Chisato Ogawa, Mika Kaneki, Nanaho Saito, Emiko Mura, Risako Suzuki, Toshiaki Tsurui, Nana Iriguchi, Tomoyuki Ishiguro, et al. Vinegar intake in patients undergoing immune checkpoint inhibitor therapy: food frequency questionnaire study. Frontiers in Immunology. 2025. 16. 1640603
Yoichiro Narikawa, Atsuo Kuramasu, Masahiro Hosonuma, Masakazu Murayama, Eiji Funayama, Akiko Sasaki, Yuta Baba, Hitoshi Toyoda, Junya Isobe, Kohei Tajima, et al. Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity. Cancer immunology, immunotherapy : CII. 2025. 74. 9. 289-289
Makoto Watanabe, Katsuaki Ieguchi, Takashi Shimizu, Ryotaro Ohkuma, Risako Suzuki, Emiko Mura, Nana Iriguchi, Tomoyuki Ishiguro, Yuya Hirasawa, Go Ikeda, et al. Plasma WFDC2 (HE4) as a Predictive Biomarker for Clinical Outcomes in Cancer Patients Receiving Anti-PD-1 Therapy: A Pilot Study. Cancers. 2025. 17. 14
Toshiaki Tsurui, Masahiro Hosonuma, Aya Sasaki, Yuuki Maruyama, Yasunobu Amari, Eiji Funayama, Kohei Tajima, Hitoshi Toyoda, Junya Isobe, Yoshitaka Yamazaki, et al. Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8+ T cells as a predictor of clinical benefit. Discover oncology. 2025. 16. 1. 348-348
Takashi Shimizu, Ryotaro Ohkuma, Mayumi Homma, Shingo Nakayama, Yosuke Sasaki, Satoshi Muto, Katsuaki Ieguchi, Makoto Watanabe, Akashi Taguchi, Daisuke Takayanagi, et al. Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression. Frontiers in immunology. 2025. 16. 1528594-1528594
石黒智之, 高柳大輔, 村英美子, 鶴井敏光, 鈴木梨沙子, 入口菜々, 平澤優弥, 大熊遼太朗, 有泉裕嗣, 久保田祐太郎, et al. Genetic analysis of tumor cells derived from the stress of immune response for understanding of immunotherapy. 日本臨床腫瘍学会学術集会(CD-ROM). 2024. 21st
Nivolumab-induced cold agglutinin disease as an immune-related adverse event in esophageal cancer
(The 87th Annual Meeting of the Japanese Society of Hematology 2025)
Impact of food consumption for response of immune checkpoint inhibitor ther apy: food frequency questionnaire study (updated).
(The 29th Annual Meeting of Japanese Association of Cancer Immunology 2025)
